Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

Texas Will Launch Ibogaine Clinical Trials After Drug Companies Failed To Meet Requirements For Psychedelic Research Funds

“We intend to fully fund this program.” By Stephen Simpson, The Texas Tribune Texas is launching its own research program into a psychedelic called ibogaine after state officials couldn’t find a company to help develop it into a drug for Food and Drug Administration (FDA) approval. Lt. Gov. Dan Patrick (R) and House Speaker Dustin Burrows (R) announced on Tuesday that Texas will use $50 million the Legislature invested last year and partner with…

Texas to conduct its own ibogaine clinical trials

The Legislature last year approved $50 million to research the psychedelic and find a company to develop it into a drug for FDA approval.

Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

The Legislature last year approved $50 million to research the psychedelic and find a company to develop it into a drug for FDA approval.

Texas Will Conduct Clinical Trials Of Psychedelic Drug Ibogaine – 710am KURV

Texas plans to start a research program into a psychedelic drug called ibogaine. House Speaker Dustin Burrows and Lieutenant Governor Dan Patrick announced the 50-million-dollar program on Tuesday. They said the state couldn’t find a drug company to help develop ibogaine into a medication for FDA approval. The legislature wanted companies to set up a corporate presence in Texas, match the state’s 50-million-dollar investment, and agree to give T…